Greenwich LifeSciences

BioAtla, Inc. , Virios Therapeutics, Inc. and Scopus BioPharma Inc. brought the number of initial public offerings by biopharmaceutical companies in the US to 85 so far in 2020 as investors prepar

Initial public offerings in the US have been remarkable across industries, but the biopharmaceutical sector has dominated in terms of the number of IPOs and the performance of newly issued stocks in t